AN2 Therapeutics, Inc. Common Stock
$4.88
▼ 0.01
(-0.20%)
Volume: 155,127
· 2026-09-25
Loading…
RSI (14)
🧭 Style Verdicts
🚀
Momentum
38
- 21d momentum -11.8%
- RSI 36
🎯
Pullback
62
- Near lower Bollinger band
- -9.5% vs 20MA
💎
Value
58
- -32% off 52w high
Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.
📐 Technicals
RSI(14)36.2
MACD-0.081
MA trendMixed
ATR7.14%
21d mom.-11.8%
63d mom.-6.2%
vs 20MA-9.5%
RVOL(20)0.66×
52w low · 1
52w high · 7
-32.1% from 52-week high
20d support 5
· resistance 6
Computed live from daily OHLCV · as of 2026-09-25
🏦 Fundamentals
Market cap$185M
PER—
PBR2.43
PSR—
EPS$-0.96
ROE-47.8%
ROA-44.4%
Dividend yield0.00%
Debt/Equity0.00
EV/EBITDA-3.61
| week | 1M | 3M | 6M | 1Y | YTD |
|---|---|---|---|---|---|
| -3.37% | -11.75% | -6.15% | +35.18% | +282.75% | +339.64% |
Valuation and profitability in USD, latest reported 2026-09-24. Period returns are price-based.
⚖️ AI Bull vs Bear
14d momentum -17.15%, daily vol 3.13%. AN2 Therapeutics, Inc. Common Stock sits in a bearish regime.
Derived from 14-day momentum and daily volatility on real OHLCV.
🗞 Related News
No recent news.